Stockreport

Ischemic Heart Disease (IHD) Drugs Strategic Research Report 2024: Market to Grow by $1.1 Billion During 2023-2030, Driven by Increasing Demand for Combination Therapies [Yahoo! Finance]

Amgen Inc.  (AMGN) 
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
PDF The global market for Ischemic Heart Disease (IHD) Drugs was estimated at US$6.1 Billion in 2023 and is projected to reach US$7.2 Billion by 2030, growing at a CAGR of [Read more]